DATROWAY AstraZeneca Pty Ltd

DATROWAY( datopotamab deruxtecan) is proposed to treat adults with a type of breast cancer called triple‑negative breast cancer that has spread or cannot be removed with surgery. It is for patients who are not able to receive treatments that affect the PD‑1 or PD‑L1 immune system pathway.